CONNECT WITH US
HealthTech

HealthTech

China climbed biotech's worry list, while Big Pharma kept shopping

Endpoints News logo

Published on

Add as a preferred source on Google
China climbed biotech's worry list, while Big Pharma kept shopping

Biotech turns on Chi­na while Big Phar­ma keeps shop­ping its pipeline: Sig­nal Sur­vey

In the months lead­ing up to the Trea­sury De­part­ment’s re­lease of draft rules that would lim­it US in­vest­ment in Chi­nese bio­phar­ma, the …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

No­vo won't launch Ca­griSe­ma in Eu­rope for 'a cou­ple of years,' CFO says

Ul­tragenyx to lay off 20% of em­ploy­ees, scrap a Wil­son dis­ease gene ther­a­py

CStone de­liv­ered two Rapid Oral pre­sen­ta­tions at ES­MO 2026, ad­vanc­ing clin­i­cal val­i­da­tion of CS2009



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.